ADVERSE CARDIOVASCULAR EVENTS WITH IMMUNE CHECKPOINT INHIBITORS AND ASSOCIATIONS WITH PATIENT OUTCOMES

被引:0
|
作者
Hathaway, Quincy
Yanamala, Naveena
Patel, Brijesh D.
机构
[1] West Virginia Univ, Sch Med, Morgantown, WV USA
[2] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1925 / 1925
页数:1
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
    Karhapaa, Hanna
    Makela, Siru
    Lauren, Hanna
    Jaakkola, Marjut
    Schalin-Jantti, Camilla
    Hernberg, Micaela
    ENDOCRINE CONNECTIONS, 2022, 11 (02)
  • [2] Immune checkpoint inhibitors associated cardiovascular immune-related adverse events
    Jo, Wonyoung
    Won, Taejoon
    Daoud, Abdel
    Cihakova, Daniela
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] Adverse Events of Immune Checkpoint Inhibitors
    Foller, S.
    Oppel-Heuchel, H.
    Fetter, I.
    Winkler, Y.
    Grimm, M. -O.
    UROLOGE, 2017, 56 (04): : 486 - 491
  • [4] Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
    Luo, Lingli
    Liu, Yuxin
    Lu, Jingfen
    Zhang, Yifei
    Fan, Gang
    Tang, Xiaojun
    Guo, Weiming
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
    Jessica Castrillon Lal
    Sherry-Ann Brown
    Patrick Collier
    Feixiong Cheng
    Cardio-Oncology, 7
  • [6] A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
    Lal, Jessica Castrillon
    Brown, Sherry-Ann
    Collier, Patrick
    Cheng, Feixiong
    CARDIO-ONCOLOGY, 2021, 7 (01)
  • [7] Germline, somatic and clinical associations with response to Immune Checkpoint Inhibitors and adverse events in a large patient cohort
    Groha, S.
    Abou Alaiwi, S.
    Taraszka, K.
    Lepisto, E.
    Manos, M.
    Rahma, O.
    Choueiri, T.
    Freedman, M. L.
    Schrag, D.
    Kehl, K.
    Gusev, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 92 - 92
  • [8] Treatment outcomes of cutaneous adverse events to immune checkpoint inhibitors.
    Wu, Jennifer
    Freites-Martinez, Azael
    Hellmann, Matthew David
    Rosenberg, Jonathan E.
    Motzer, Robert J.
    Chapman, Paul B.
    Rizvi, Naiyer A.
    Geskin, Larisa J.
    Reed, Vanessa A.
    Dusza, Stephen W.
    Markova, Alina
    Callahan, Margaret K.
    Chan, Donald
    Lopez, Adriana
    Yang, Chih-Hsun
    Chung, Wen-Hung
    Lacouture, Mario E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Cardiovascular adverse events associated with immune checkpoint inhibitors: a meta-analysis
    Li, Xi
    Li, Dan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [10] Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors
    Kwan, Jennifer M.
    Shen, Miles
    Akhlaghi, Narjes
    Hu, Jiun-Ruey
    Mora, Ruben
    Cross, James L.
    Jiang, Matthew
    Mankbadi, Michael
    Wang, Peter
    Zaman, Saif
    Lee, Seohyuk
    Im, Yunju
    Feher, Attila
    Liu, Yi-Hwa
    Ma, Shuangge S.
    Tao, Weiwei
    Wei, Wei
    Baldassarre, Lauren A.
    PLOS ONE, 2024, 19 (12):